Tomorrow's a Big Day

Shhh. Hear that buzzing sound? It's people discussing what may happen tomorrow at the FDA's Arthritis Advisory Committee meeting. There, experts will be debating whether another COX-2 drug, etoricoxib (Arcoxia), will likely be recommended for approval. Arcoxia is a successor to the now-defunct Vioxx in that it's another COX-2 manufactured by Merck. Safety of patients versus the need for treatment options for patients likely will be the hot topic. I'll be watching and listening as the news unfolds, but I'm curious in what you think the outcome will be. No water-cooler bets have been placed around here, as far as I know, but go ahead and take a guess. Let me know if you think the FDA committee will recommend it be approved or sends it back to the drawing board -- why or why not? And be sure to let me know what you wish/hope will happen tomorrow and in the future.

Donna